IC50 | 500 nM | Apoptosis regulator Bcl-X | Q07817 | |
Ki | 320 nM | Apoptosis regulator Bcl-2 | P10415 | |
IC50 | 500 nM | Apoptosis regulator Bcl-2 | P10415 | |
Ki | 480 nM | Apoptosis regulator Bcl-X | Q07817 | |
Ki | 180 nM | Induced myeloid leukemia cell differentiation protein Mcl-1 | Q07820 | |
Ki | 170 nM | Apoptosis regulator Bcl-2 | P10415 | |
Ki | 280 nM | Induced myeloid leukemia cell differentiation protein Mcl-1 | Q07820 | |
Ki | 10100 nM | Apoptosis regulator Bcl-2 | P10415 | |
Ki | 17700 nM | Apoptosis regulator Bcl-W | Q92843 | |
Others | 60 % | Estradiol 17-beta-dehydrogenase 1 | P14061 | |
Others | 64.8 % | Estradiol 17-beta-dehydrogenase 2 | P37059 | |
Potency | 19952.6 nM | Ubiquitin carboxyl-terminal hydrolase 2 | O75604 | |
Potency | 2238.7 nM | Prelamin-A/C | P02545 | |
Potency | 44668.4 nM | Thyroid hormone receptor beta-1 | P10828 | |
Potency | 44668.4 nM | Thyroid hormone receptor beta-1 | P10828 | |
Potency | 50118.7 nM | Thyroid hormone receptor beta-1 | P10828 | |
Potency | 12589.3 nM | ATP-dependent DNA helicase Q1 | P46063 | |
Potency | 23690.6 nM | Galactokinase | P51570 | |
Potency | 3162.3 nM | ATP-dependent DNA helicase Q1 | P46063 | |
Potency | 17782.8 nM | ATP-dependent DNA helicase Q1 | P46063 | |
Potency | 5011.9 nM | ATP-dependent DNA helicase Q1 | P46063 | |
Potency | 5011.9 nM | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | |
Potency | 7943.3 nM | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | |
Potency | 15848.9 nM | ATP-dependent DNA helicase Q1 | P46063 | |
Potency | 14125.4 nM | ATP-dependent DNA helicase Q1 | P46063 | |
Potency | 3548.1 nM | Lysine-specific demethylase 4D-like | B2RXH2 | |
Potency | 7943.3 nM | Lysine-specific demethylase 4D-like | B2RXH2 | |
Potency | 7943.3 nM | Lysine-specific demethylase 4D-like | B2RXH2 | |
Potency | 6309.6 nM | Lysine-specific demethylase 4D-like | B2RXH2 | |
Potency | 7079.5 nM | Lysine-specific demethylase 4D-like | B2RXH2 | |
Potency | 12589.3 nM | Huntingtin | P42858 | |
Potency | 12589.3 nM | Caspase-1 | P29466 | |
Potency | 19952.6 nM | Caspase-7 | P55210 | |
Potency | 58047.9 nM | Ras-related protein Rab-9A | P51151 | |
Potency | 35481.3 nM | Survival motor neuron protein | Q16637 | |
Potency | 35481.3 nM | Survival motor neuron protein | Q16637 | |
Potency | 25118.9 nM | Caspase-1 | P29466 | |
Potency | 14689.2 nM | Serine/threonine-protein kinase mTOR | P42345 | |
Potency | 5623.4 nM | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | |
Potency | 11220.2 nM | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | |
Potency | 25118.9 nM | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | |
Potency | 14125.4 nM | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | |
Potency | 8912.5 nM | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | |
Potency | 39810.7 nM | Thyroid hormone receptor beta-1 | P10828 | |
Potency | 35481.3 nM | Thyroid hormone receptor beta-1 | P10828 | |
Potency | 6309.6 nM | Cytochrome P450 2C19 | P33261 | |
Potency | 31622.8 nM | Thyroid hormone receptor beta-1 | P10828 | |
Potency | 25118.9 nM | Thyroid hormone receptor beta-1 | P10828 | |
Potency | 17782.8 nM | Thyroid hormone receptor beta-1 | P10828 | |
Potency | 39810.7 nM | Thyroid hormone receptor beta-1 | P10828 | |
Potency | 25118.9 nM | Microtubule-associated protein tau | P10636 | |
Potency | 31622.8 nM | Microtubule-associated protein tau | P10636 | |
Potency | 19952.6 nM | Microtubule-associated protein tau | P10636 | |
Potency | 28183.8 nM | Microtubule-associated protein tau | P10636 | |
Potency | 22387.2 nM | Microtubule-associated protein tau | P10636 | |
Potency | 10000 nM | Hypoxia-inducible factor 1 alpha | Q16665 | |
Potency | 11220.2 nM | Aldehyde dehydrogenase 1A1 | P00352 | |
Potency | 39810.7 nM | Aldehyde dehydrogenase 1A1 | P00352 | |
Potency | 2612.2 nM | Serine/threonine-protein kinase mTOR | P42345 | |
Potency | 10000 nM | Arachidonate 15-lipoxygenase | P16050 | |
Potency | 10000 nM | Arachidonate 15-lipoxygenase | P16050 | |
Potency | 35481.3 nM | Microtubule-associated protein tau | P10636 | |
Potency | 25118.9 nM | Microtubule-associated protein tau | P10636 | |
Potency | 10000 nM | Hypoxia-inducible factor 1 alpha | Q16665 | |
Potency | 26121.6 nM | Serine/threonine-protein kinase mTOR | P42345 | |
Potency | 25118.9 nM | MAP kinase ERK2 | P28482 | |
Potency | 891.3 nM | Arachidonate 12-lipoxygenase | P18054 | |
Potency | 22387.2 nM | Microtubule-associated protein tau | P10636 | |
Potency | 35481.3 nM | Microtubule-associated protein tau | P10636 | |
Potency | 35481.3 nM | Microtubule-associated protein tau | P10636 | |
Potency | 2511.9 nM | Arachidonate 12-lipoxygenase | P18054 | |
Potency | 5011.9 nM | Arachidonate 12-lipoxygenase | P18054 | |
Potency | 316.2 nM | Arachidonate 12-lipoxygenase | P18054 | |
IC50 | 2551.34 nM | Estrogen receptor alpha | P03372 | |
Potency | 15848.9 nM | Caspase-1 | P29466 | |
Potency | 91999.7 nM | Niemann-Pick C1 protein | O15118 | |
Potency | 1995.3 nM | Ubiquitin carboxyl-terminal hydrolase 2 | O75604 | |
Potency | 28183.8 nM | MAP kinase ERK2 | P28482 | |
Potency | 12589.3 nM | Caspase-7 | P55210 | |
Potency | 35481.3 nM | MAP kinase ERK2 | P28482 | |
IC50 | 1523.1 nM | Induced myeloid leukemia cell differentiation protein Mcl-1 | Q07820 | |
Potency | 25118.9 nM | Ubiquitin carboxyl-terminal hydrolase 2 | O75604 | |
Potency | 25118.9 nM | Caspase-1 | P29466 | |
Potency | 8912.5 nM | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | |
Potency | 14689.2 nM | Serine/threonine-protein kinase mTOR | P42345 | |
Potency | 14125.4 nM | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | |
Potency | 35481.3 nM | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | |
Potency | 35481.3 nM | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | |
Potency | 12589.3 nM | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | |
Potency | 19952.6 nM | Cellular tumor antigen p53 | P04637 | |
Potency | 5011.9 nM | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | |
Potency | 15848.9 nM | Cellular tumor antigen p53 | P04637 | |
Potency | 19952.6 nM | Cellular tumor antigen p53 | P04637 | |
Potency | 12589.3 nM | Caspase-1 | P29466 | |
Potency | 10000 nM | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | |
Potency | 28183.8 nM | Bloom syndrome protein | P54132 | |
Potency | 8912.5 nM | Lysosomal alpha-glucosidase | P10253 | |
Potency | 17782.8 nM | Bloom syndrome protein | P54132 | |
Potency | 31622.8 nM | Bloom syndrome protein | P54132 | |
Potency | 12589.3 nM | Neuropeptide S receptor | Q6W5P4 | |
Potency | 35481.3 nM | Bloom syndrome protein | P54132 | |
Potency | 28183.8 nM | Bloom syndrome protein | P54132 | |
Potency | 31622.8 nM | Cytochrome P450 2D6 | P10635 | |
Potency | 31622.8 nM | Cytochrome P450 3A4 | P08684 | |
Potency | 15848.9 nM | Caspase-7 | P55210 | |
Potency | 562.3 nM | DNA polymerase beta | P06746 | |
Potency | 5211.9 nM | Ubiquitin carboxyl-terminal hydrolase 2 | O75604 | |
Potency | 22387.2 nM | ATP-dependent DNA helicase Q1 | P46063 | |
Potency | 31622.8 nM | Cytochrome P450 3A4 | P08684 | |
Potency | 31622.8 nM | Cytochrome P450 2C9 | P11712 | |
Potency | 15848.9 nM | Cytochrome P450 2C9 | P11712 | |
Potency | 14581 nM | Nuclear factor erythroid 2-related factor 2 | Q16236 | |
Potency | 12589.3 nM | Dopamine D1 receptor | P21728 | |
Potency | 19952.6 nM | Histone acetyltransferase GCN5 | Q92830 | |
Potency | 10000 nM | Histone acetyltransferase GCN5 | Q92830 | |
Potency | 7943.3 nM | Histone acetyltransferase GCN5 | Q92830 | |
Potency | 15003 nM | M-phase phosphoprotein 8 | Q99549 | |
Potency | 29092.9 nM | ATPase family AAA domain-containing protein 5 | Q96QE3 | |
Potency | 11220.2 nM | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Q96KQ7 | |
Potency | 35481.3 nM | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Q96KQ7 | |
Potency | 9466.2 nM | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Q96KQ7 | |
Potency | 10000 nM | Chromobox protein homolog 1 | P83916 | |
Potency | 15848.9 nM | Bromodomain adjacent to zinc finger domain protein 2B | Q9UIF8 | |
Potency | 10000 nM | Arachidonate 15-lipoxygenase, type II | O15296 | |
Potency | 3548.1 nM | Arachidonate 15-lipoxygenase, type II | O15296 | |
Potency | 5011.9 nM | Arachidonate 15-lipoxygenase, type II | O15296 | |
Potency | 9528.3 nM | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Q13526 | |
Potency | 8196.1 nM | ATPase family AAA domain-containing protein 5 | Q96QE3 | |
Potency | 22387.2 nM | Dopamine D1 receptor | P21728 | |
Potency | 11917.3 nM | Flap endonuclease 1 | P39748 | |
Potency | 44668.4 nM | Nuclear factor NF-kappa-B p105 subunit | P19838 | |
Potency | 12589.3 nM | Cellular tumor antigen p53 | P04637 | |
Potency | 1694.4 nM | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Q13526 | |
Potency | 27306 nM | Nuclear factor erythroid 2-related factor 2 | Q16236 | |
Potency | 35481.3 nM | Glutaminase kidney isoform, mitochondrial | O94925 | |
Potency | 18356.4 nM | Geminin | O75496 | |
Potency | 15848.9 nM | Ataxin-2 | Q99700 | |
Potency | 10000 nM | Ataxin-2 | Q99700 | |
Potency | 1694.4 nM | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Q13526 | |
Potency | 15848.9 nM | Peroxisome proliferator-activated receptor alpha | Q07869 | |
Kd | 2324 nM | Induced myeloid leukemia cell differentiation protein Mcl-1 | Q07820 | |
Ki | 190 nM | Induced myeloid leukemia cell differentiation protein Mcl-1 | Q07820 | |
Ki | 213.8 nM | Induced myeloid leukemia cell differentiation protein Mcl-1 | Q07820 | |
Kd | 4800 nM | Apoptosis regulator Bcl-2 | P10415 | |
Kd | 2650 nM | Induced myeloid leukemia cell differentiation protein Mcl-1 | Q07820 | |
IC50 | 4800 nM | Induced myeloid leukemia cell differentiation protein Mcl-1 | Q07820 | |
IC50 | 170 nM | Induced myeloid leukemia cell differentiation protein Mcl-1 | Q07820 | |
Kd | 2630.27 nM | Induced myeloid leukemia cell differentiation protein Mcl-1 | Q07820 | |
Kd | 2650 nM | Induced myeloid leukemia cell differentiation protein Mcl-1 | Q07820 | |
IC50 | 10800 nM | Kinesin-like protein 1 | P52732 | |
IC50 | 2110 nM | Apoptosis regulator Bcl-2 | P10415 | |
Ki | 558 nM | Apoptosis regulator Bcl-2 | P10415 | |
Ki | 190 nM | Induced myeloid leukemia cell differentiation protein Mcl-1 | Q07820 | |
IC50 | 3000 nM | DNA-3-methyladenine glycosylase | P29372 | |
Ki | 1000 nM | Apoptosis regulator Bcl-X | Q07817 | |
Ki | 620 nM | Apoptosis regulator Bcl-X | Q07817 | |
Ki | 640 nM | Apoptosis regulator Bcl-X | Q07817 | |
Ki | 310 nM | Induced myeloid leukemia cell differentiation protein Mcl-1 | Q07820 | |
Ki | 390 nM | Induced myeloid leukemia cell differentiation protein Mcl-1 | Q07820 | |
Ki | 770 nM | Apoptosis regulator Bcl-X | Q07817 | |
Ki | 560 nM | Apoptosis regulator Bcl-2 | P10415 | |
Ki | 1900 nM | L-lactate dehydrogenase A chain | P00338 | |
Ki | 1400 nM | L-lactate dehydrogenase B chain | P07195 | |
Ki | 260 nM | Induced myeloid leukemia cell differentiation protein Mcl-1 | Q07820 | |
Ki | 431 nM | Apoptosis regulator Bcl-2 | P10415 | |
Ki | 25000 nM | p53-binding protein Mdm-2 | Q00987 | |
Others | 100 % | Apoptosis regulator Bcl-2 | P10415 | |
Ki | 440 nM | Apoptosis regulator Bcl-2 | P10415 | |
Others | 100 % | Apoptosis regulator Bcl-X | Q07817 | |
Ki | 310 nM | Apoptosis regulator Bcl-X | Q07817 | |